Early Phase 1 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 90 years old, your doctor suspects you may have multiple myeloma, and you are scheduled to have a bone marrow or tissue sample taken within the next 3 months
- You are over 18 years old and have already been diagnosed with active multiple myeloma
- You fully understand what the study involves, are willing to take part, and are able to sign a consent form
- You are able to follow the study procedures on your own
Who may not be able to join:
- You are currently pregnant
- You are unable to understand or follow the study examination process for any reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lei Kang, MD, Peking University First Hospital
Phone: +8613439014669
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Specificity and Binding Efficiency of 68Ga-NB381 in CD38 Positive Tumors; Baseline Pathological Characteristics: Histopathology, Flow Cytometry, and Immunohistochemistry
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.